Dry AMD and Geographic Atrophy 2024
Videos
Implementing Modern Diagnosis and Management Approaches in Today’s Practice
IME Video Interviews
Optimizing Patient Communication Masterclasses Series – Keys to patient adherence with injection therapies
Optimizing Patient Communication Masterclasses Series – Best practices for enhancing patient education
Understanding the Impact of Dry AMD and GA
Diagnosing and Monitoring dry AMD
Implementing GA Treatments
Podcasts
Podcasts
Understanding the Impact of Dry AMD and GA
In this episode of the EURETINA IME podcast series on dry AMD and GA, Prof. Frank G. Holz and Dr. Arshad Khanani discuss the prevalence of dry AMD and GA, highlight major risk factors, and stress the profound impact of GA on patients’ quality of life. They emphasize the critical importance of early intervention to preserve vision and independence, outlining key functional and anatomical changes that can help detect progression early, allowing for timely intervention. Make sure to listen to the other podcasts in this series!
Podcasts
Diagnosing and Monitoring dry AMD
In this episode of the EURETINA IME podcast series on dry AMD and GA, Prof. Frank G. Holz and Dr. Arshad Khanani discuss essential diagnostic modalities for dry AMD, highlighting what to look for to enable an early diagnosis. They explore how to classify the disease stage using established grading systems, identify predictors of rapid disease progression, and discuss strategies for managing them. Additionally, they provide guidance on when general ophthalmologists should refer dry AMD and geographic atrophy patients to a retina specialist for further care. Make sure to listen to the other podcasts in this series!
Podcasts
Implementing GA Treatments
In this episode of the EURETINA IME podcast series on dry AMD and GA, Prof. Frank G. Holz and Dr. Arshad Khanani explore emerging complement pathway-targeting treatments for GA. They discuss key aspects, including patient selection, integrating these treatments into the GA patient workflow, and effectively communicating potential side effects. Prof. Holz and Dr. Khanani also address rare adverse events and provide recommendations on how to avoid or manage them. Finally, they share valuable real-world insights on the use of these therapies. Make sure to listen to the other podcasts in this series!
Supplements
Coming soon..
Independent medical education support provided by
Astellas Pharma & Apellis